A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
Tag: Drugs (Pharmaceuticals)
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
South Africa Built a Medical Research Powerhouse. Trump Cuts Have Demolished It.
The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug companies, too.
Used in Covid Shots, mRNA May Help Rid the Body of H.I.V.
A new study shows how the technology deployed in Covid vaccines helped scientists coax the virus out of hiding.
Europe’s Pharma Industry Braces for Pain as Trump Tariff Threat Looms
Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions drag on.
For John Green, It’s Tuberculosis All the Way Down
The best-selling author “got a little emotional” while talking with The Times about tuberculosis. Listen to the conversation.
Armed Bandits in Brazil Pursue New Loot: Ozempic
Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where many cannot afford the drugs.
Dozens of Clinical Trials Have Been Frozen in Response to Trump’s USAID Order
The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their bodies, with no access to monitoring or care.
Pause on U.S. Funding Spreads Fear of H.I.V. Spike Across Africa
Patients and health care advocates said the abrupt decision to halt U.S. funding for a lifesaving H.I.V. program led to widespread confusion. The backtracking didn’t help.
Trump Administration Halts H.I.V. Drug Distribution in Poor Countries
PEPFAR’s computer systems also are being taken offline, a sign that the program may not return, as Republican critics had hoped.